Showing results (151-160 of 158) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Cancer Research|November 15, 1994
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cellsS W Johnson, P A Swiggard, L M Handel, et al.Molecular Pharmacology|April 30, 1999
Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayersB J Maurer, M A Ihnat, C Morgan, et al.Biochemical Pharmacology|February 11, 1994
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell linesS W Johnson, R P Perez, A K Godwin, et al.British Journal of Cancer|September 14, 2006
Gene expression profiling of human ovarian tumoursS Biade, M Marinucci, J Schick, et al.British Journal of Cancer|February 24, 2005
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cellsD Roberts, J Schick, S Conway, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxelC K Obasaju, S W Johnson, A Rogatko, et al.Cancer Research|February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 scheduleR J Schilder, F P LaCreta, R P Perez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology GroupM A Bookman, W P McGuire, D Kilpatrick, et al.Pageof 16